Compounds > tanshinone
Page last updated: 2024-09-02

tanshinone and 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione

tanshinone has been researched along with 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione in 1 studies

Compound Research Comparison

Studies
(tanshinone)		Trials
(tanshinone)		Recent Studies (post-2010)
(tanshinone)		Studies
(2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione)		Trials
(2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione)		Recent Studies (post-2010) (2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione)
1,445101,033906

Protein Interaction Comparison

ProteinTaxonomytanshinone (IC50)2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.39
Cyclin-dependent kinase 4Homo sapiens (human)7.1667
G1/S-specific cyclin-D1Homo sapiens (human)7.75
N-lysine methyltransferase KMT5AHomo sapiens (human)0.435

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hu, Y; Jadhav, P; Tan, B; Tan, H; Wang, J1

Reviews

1 review(s) available for tanshinone and 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione

ArticleYear
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.
    Journal of medicinal chemistry, 2022, 06-09, Volume: 65, Issue:11

    Topics: Antiviral Agents; Coronavirus Papain-Like Proteases; COVID-19 Drug Treatment; Humans; Pandemics; Protease Inhibitors; SARS-CoV-2

2022